Solutions

COVID-19 Solution Digital Pathology CDMO BY GBC

GB SARS-CoV-2 Influenza A/B Multiplex PCR (Flu A/B, N)

A real-time RT-PCR multiplexed test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2 (SC2), influenza A virus (Flu A), and/or influenza B virus (Flu B) nucleic acid in respiratory tract specimens.

USEFUL RESOURCES

Add to List

> FEATURE > SPECIFICATION > ORDERING INFORMATION

FEATURE

Testing for COVID-19 / FLU A / B all in one tube
Two controls to monitor the whole process
High sensitivity (LoD)
Compatible with ready-to-use GB RealQuant® AIO as well as ABI (Thermo), BioRad, Roche, Qiagen extraction and PCR systems

SPECIFICATION

Number of tests	100
Targets	SARS-CoV-2 (N gene) / Influenza A (M1) / Influenza B (NS1)
Internal Control	Pseudoviruses
Extraction Platform (compatible)	Magnetic beads / Column technology
Sample type	Respiratory specimens (i.e., nasopharyngeal/oropharyngeal swabs, nasal swabs and mid-turbinate swabs specimens)
PCR Instrument (compatible)	GB RealQuant® AIO, ABI 7500, Qiagen, Roche, Thermo, BioRad
Sensitivity (LoD)	250 copies/mL
Certification	CE

ORDERING INFORMATION

Catalogue No.	Product
4PCO102E	GB SARS-CoV-2 Influenza A/B Multiplex - 100T